Long‐lasting response to third‐line crizotinib treatment in a patient with non‐small cell lung cancer with brain metastases and poor performance status

por Li, De‐lan, Chen, Xin‐ru, Ma, Shu‐xiang, Chen, Li‐kun
Publicado 2016

Toxic epidermal necrolysis related to AP (pemetrexed plus cisplatin) and gefitinib combination therapy in a patient with metastatic non-small cell lung cancer

por Huang, Ji-Jie, Ma, Shu-Xiang, Hou, Xue, Wang, Zhao, Zeng, Yin-Duo, Qin, Tao, Dinglin, Xiao-Xiao, Chen, Li-Kun
Publicado 2015

Consolidation chemotherapy improves progression-free survival in stage III small-cell lung cancer following concurrent chemoradiotherapy: a retrospective study

por Chen, Xin-Ru, Liang, Jian-Zhong, Ma, Shu-Xiang, Fang, Wen-Feng, Zhou, Ning-Ning, Liao, Hai, Li, De-Lan, Chen, Li-Kun
Publicado 2016

Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy

por Zeng, Yin-duo, Liao, Hai, Qin, Tao, Zhang, Li, Wei, Wei-dong, Liang, Jian-zhong, Xu, Fei, Dinglin, Xiao-xiao, Ma, Shu-xiang, Chen, Li-kun
Publicado 2015

Treatment Patterns and Survival Outcomes of Non-Small Cell Lung Cancer Patients Initially Diagnosed With Brain Metastases in Real-World Clinical Practice

por Chen, Xin-Ru, Hou, Xue, Dinglin, Xiao-Xiao, Liu, Yong-Dong, Li, Yin, Zheng, Wei, Li, De-Lan, Chen, Jing, Wu, Xiao-Liang, Wang, Kai-Cheng, Ma, Shu-Xiang, Zeng, Yin-Duo, Chen, Li-Kun
Publicado 2020